CRISPR technologies revolutionized how scientists manipulate genomes. Researchers now easily edit DNA in record time; however, when performing large-scale genome engineering they must choose between introducing one type of edit throughout a genome or creating multiple edits at a single location. Inscripta’s new CRISPR-based technology gives scientists the power to do both in bacteria and yeast, right on their benchtops. The company’s advanced CRISPR-based platform, consisting of an instrument, consumables, software, and assays, offers a fully automated workflow that enables massively parallel, trackable editing of single cells at an unprecedented scale.
Download this ebook from Inscripta to learn about